Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo

The cell surface glycoprotein CD44 is expressed in cancer cells and has been used as a therapeutic target in preclinical studies. However, the ubiquitous expression of CD44 in numerous cell types, including hematopoietic cells, has hindered its application in targeted therapy. Here, we demonstrated...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Yang, Cuixia, He, Yiqing, Zhang, Huizhen, Liu, Yiwen, Wang, Wenjuan, Du, Yan, Gao, Feng
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558151/
https://ncbi.nlm.nih.gov/pubmed/25909172
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki